These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

294 related items for PubMed ID: 26975224

  • 1. The Wearable Cardioverter Defibrillator in Nonischemic Cardiomyopathy: A US National Database Analysis.
    Salehi N, Nasiri M, Bianco NR, Opreanu M, Singh V, Satija V, Jhand AS, Karapetyan L, Safadi AR, Surapaneni P, Thakur RK.
    Can J Cardiol; 2016 Oct; 32(10):1247.e1-1247.e6. PubMed ID: 26975224
    [Abstract] [Full Text] [Related]

  • 2. Use of the wearable cardioverter defibrillator in high-risk cardiac patients: data from the Prospective Registry of Patients Using the Wearable Cardioverter Defibrillator (WEARIT-II Registry).
    Kutyifa V, Moss AJ, Klein H, Biton Y, McNitt S, MacKecknie B, Zareba W, Goldenberg I.
    Circulation; 2015 Oct 27; 132(17):1613-9. PubMed ID: 26316618
    [Abstract] [Full Text] [Related]

  • 3. Wearable cardioverter-defibrillator as a bridge to cardiac transplantation: A national database analysis.
    Opreanu M, Wan C, Singh V, Salehi N, Ahmad J, Szymkiewicz SJ, Thakur RK.
    J Heart Lung Transplant; 2015 Oct 27; 34(10):1305-9. PubMed ID: 26094085
    [Abstract] [Full Text] [Related]

  • 4. Experience with the wearable cardioverter-defibrillator in older patients: Results from the Prospective Registry of Patients Using the Wearable Cardioverter-Defibrillator.
    Daimee UA, Vermilye K, Moss AJ, Goldenberg I, Klein HU, McNitt S, Zareba W, Kutyifa V.
    Heart Rhythm; 2018 Sep 27; 15(9):1379-1386. PubMed ID: 29678779
    [Abstract] [Full Text] [Related]

  • 5. The US Experience of the Wearable Cardioverter-Defibrillator in Pediatric Patients.
    Spar DS, Bianco NR, Knilans TK, Czosek RJ, Anderson JB.
    Circ Arrhythm Electrophysiol; 2018 Jul 27; 11(7):e006163. PubMed ID: 29945928
    [Abstract] [Full Text] [Related]

  • 6. Ventricular arrhythmias in patients with newly diagnosed nonischemic cardiomyopathy: Insights from the PROLONG study.
    Duncker D, König T, Hohmann S, Bauersachs J, Veltmann C.
    Clin Cardiol; 2017 Aug 27; 40(8):586-590. PubMed ID: 28333373
    [Abstract] [Full Text] [Related]

  • 7. Utility of the Wearable Cardioverter-Defibrillator in Patients With Newly Diagnosed Cardiomyopathy: A Decade-Long Single-Center Experience.
    Singh M, Wang NC, Jain S, Voigt AH, Saba S, Adelstein EC.
    J Am Coll Cardiol; 2015 Dec 15; 66(23):2607-2613. PubMed ID: 26670060
    [Abstract] [Full Text] [Related]

  • 8. Therapy optimization in patients with heart failure: the role of the wearable cardioverter-defibrillator in a real-world setting.
    Röger S, Rosenkaimer SL, Hohneck A, Lang S, El-Battrawy I, Rudic B, Tülümen E, Stach K, Kuschyk J, Akin I, Borggrefe M.
    BMC Cardiovasc Disord; 2018 Mar 15; 18(1):52. PubMed ID: 29544442
    [Abstract] [Full Text] [Related]

  • 9. Extended use of the wearable cardioverter-defibrillator in patients at risk for sudden cardiac death.
    Kutyifa V, Vermilye K, Daimee UA, McNitt S, Klein H, Moss AJ.
    Europace; 2018 Sep 01; 20(FI2):f225-f232. PubMed ID: 29905788
    [Abstract] [Full Text] [Related]

  • 10. Potential roles of the wearable cardioverter-defibrillator in acute phase care of patients at high risk of sudden cardiac death: A single-center Japanese experience.
    Sasaki S, Shoji Y, Ishida Y, Kinjo T, Tsushima Y, Seno M, Nishizaki F, Itoh T, Izumiyama K, Yokota T, Yokoyama H, Yamada M, Horiuchi D, Kimura M, Higuma T, Tomita H, Okumura K.
    J Cardiol; 2017 Jan 01; 69(1):359-363. PubMed ID: 27595899
    [Abstract] [Full Text] [Related]

  • 11. The wearable cardioverter-defibrillator in a real-world clinical setting: experience in 102 consecutive patients.
    Erath JW, Vamos M, Sirat AS, Hohnloser SH.
    Clin Res Cardiol; 2017 Apr 01; 106(4):300-306. PubMed ID: 27888304
    [Abstract] [Full Text] [Related]

  • 12. Outcomes during and after the use of the wearable cardioverter-defibrillator in a tertiary-care and a regional hospital in Switzerland.
    Kovacs B, Reek S, Saguner AM, Krasniqi N, Eriksson U, Duru F.
    Swiss Med Wkly; 2019 Nov 04; 149():w20136. PubMed ID: 31707723
    [Abstract] [Full Text] [Related]

  • 13. Long-term use of the wearable cardioverter defibrillator in patients with explanted ICD.
    Kaspar G, Sanam K, Gholkar G, Bianco NR, Szymkiewicz S, Shah D.
    Int J Cardiol; 2018 Dec 01; 272():179-184. PubMed ID: 30121177
    [Abstract] [Full Text] [Related]

  • 14. Use of the wearable cardioverter-defibrillator (WCD) and WCD-based remote rhythm monitoring in a real-life patient cohort.
    Zylla MM, Hillmann HAK, Proctor T, Kieser M, Scholz E, Zitron E, Katus HA, Thomas D.
    Heart Vessels; 2018 Nov 01; 33(11):1390-1402. PubMed ID: 29721674
    [Abstract] [Full Text] [Related]

  • 15. National experience with long-term use of the wearable cardioverter defibrillator in patients with cardiomyopathy.
    Lamichhane M, Gardiner JC, Bianco NR, Szymkiewicz SJ, Thakur RK.
    J Interv Card Electrophysiol; 2017 Jan 01; 48(1):11-19. PubMed ID: 27752809
    [Abstract] [Full Text] [Related]

  • 16. Wearable cardioverter-defibrillator use in patients perceived to be at high risk early post-myocardial infarction.
    Epstein AE, Abraham WT, Bianco NR, Kern KB, Mirro M, Rao SV, Rhee EK, Solomon SD, Szymkiewicz SJ.
    J Am Coll Cardiol; 2013 Nov 19; 62(21):2000-2007. PubMed ID: 23916930
    [Abstract] [Full Text] [Related]

  • 17. Avoiding Untimely Implantable Cardioverter/Defibrillator Implantation by Intensified Heart Failure Therapy Optimization Supported by the Wearable Cardioverter/Defibrillator-The PROLONG Study.
    Duncker D, König T, Hohmann S, Bauersachs J, Veltmann C.
    J Am Heart Assoc; 2017 Jan 17; 6(1):. PubMed ID: 28096098
    [Abstract] [Full Text] [Related]

  • 18. Clinical experience with wearable cardioverter defibrillators at a tertiary electrophysiology program.
    Bossory L, Schubert S, Afzal MR, Weiss R, Tyler J, Kalbfleisch S, Augostini R, Hummel J, Okabe T, Daoud EG, Houmsse M.
    Pacing Clin Electrophysiol; 2018 Nov 17; 41(11):1491-1494. PubMed ID: 30191582
    [Abstract] [Full Text] [Related]

  • 19. A Patch Wearable Cardioverter-Defibrillator for Patients at Risk of Sudden Cardiac Arrest.
    Hummel J, Houmsse M, Tomassoni G, Nair D, Romero J, Hargrove J, Mathews K, Thakkar AB, Ullery S, Eapen ZJ, Kumar UN, Mehran R, Butler J, Jewel IDE Study Investigators.
    J Am Coll Cardiol; 2024 Aug 06; 84(6):525-536. PubMed ID: 39084827
    [Abstract] [Full Text] [Related]

  • 20. Use of the Wearable Cardioverter Defibrillator in High-Risk Populations.
    Lamichhane M, Safadi A, Surapaneni P, Salehi N, Thakur RK.
    Curr Cardiol Rep; 2016 Aug 06; 18(8):78. PubMed ID: 27319008
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.